Tff Pharmaceuticals Stock Price To Sales
Tff Pharmaceuticals fundamentals help investors to digest information that contributes to Tff Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Tff Stock. The fundamental analysis module provides a way to measure Tff Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tff Pharmaceuticals stock.
Tff |
Tff Pharmaceuticals Company Price To Sales Analysis
Tff Pharmaceuticals' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Tff Pharmaceuticals Price To Sales | 0.24 X |
Most of Tff Pharmaceuticals' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tff Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Tff Pharmaceuticals has a Price To Sales of 0.2401 times. This is 98.88% lower than that of the Pharmaceuticals sector and 99.76% lower than that of the Health Care industry. The price to sales for all United States stocks is 97.9% higher than that of the company.
Tff Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tff Pharmaceuticals' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tff Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Tff Pharmaceuticals by comparing valuation metrics of similar companies.Tff Pharmaceuticals is currently under evaluation in price to sales category among its peers.
Tff Fundamentals
| Return On Equity | -2.14 | ||||
| Return On Asset | -1.06 | ||||
| Operating Margin | (6.09) % | ||||
| Current Valuation | (2.27 M) | ||||
| Shares Outstanding | 4.44 M | ||||
| Shares Owned By Insiders | 3.31 % | ||||
| Shares Owned By Institutions | 24.37 % | ||||
| Number Of Shares Shorted | 157.16 K | ||||
| Price To Book | 0.09 X | ||||
| Price To Sales | 0.24 X | ||||
| Revenue | 733.87 K | ||||
| Gross Profit | (21.21 M) | ||||
| EBITDA | (20.74 M) | ||||
| Net Income | (21.24 M) | ||||
| Cash And Equivalents | 13.15 M | ||||
| Cash Per Share | 0.51 X | ||||
| Total Debt | 115.25 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 8.18 X | ||||
| Book Value Per Share | 4.04 X | ||||
| Cash Flow From Operations | (16.04 M) | ||||
| Short Ratio | 1.77 X | ||||
| Earnings Per Share | (5.50) X | ||||
| Target Price | 30.0 | ||||
| Number Of Employees | 19 | ||||
| Beta | 1.32 | ||||
| Market Capitalization | 288.8 K | ||||
| Total Asset | 12.03 M | ||||
| Retained Earnings | (118.33 M) | ||||
| Working Capital | 5.16 M | ||||
| Net Asset | 12.03 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Tff Stock
If you are still planning to invest in Tff Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tff Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |